✦ LIBER ✦

Pharmaceutical Aspects of Combined Vaccines: A Manufacturer's Perspective

✍ Scribed by J.R. Vose

Book ID: 112237482
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 222 KB
Volume: 22
Category: Article
ISSN: 1045-1056
DOI: 10.1006/biol.1994.1051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conclusions of Workshop I: Pharmaceutica

Conclusions of Workshop I: Pharmaceutical Aspects of Combined Vaccines

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Business perspectives of a European vacc

Business perspectives of a European vaccine manufacturer

✍ Walter Vandersmissen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 51 KB

MOCVD of Electroceramic Oxides: A Precur

MOCVD of Electroceramic Oxides: A Precursor Manufacturer′s Perspective

✍ Anthony C. Jones 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Second European Conference on Vaccinolog

Second European Conference on Vaccinology: Combined Vaccines for Europe: Pharmaceutical, Regulatory and Policy Making Aspects

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Second European Conference on Vaccinolog

Second European Conference on Vaccinology: Combined vaccines for Europe: Pharmaceutical, Regulatory and Policy-Making Aspects

✍ K. Vandendaed 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Pharmaceutical aspects of intranasal del

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

✍ Sameer Sharma; T.K.S. Mukkur; Heather A.E. Benson; Yan Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

The nasal route offers a promising opportunity for the delivery of vaccines. This review analyses the opportunities and novel delivery strategies based on particulate systems for the nasal delivery of vaccines, including liposomes, proteosomes, virosomes, nano-and microparticulate systems, with and